Results 161 to 170 of about 160,832 (337)
Clinical validation of a DNA methylation biomarker associated with overall survival of relapsed ovarian cancer patients
International Journal of Cancer, EarlyView.What's New?
Most patients with ovarian cancer (OC) relapse after first‐line chemotherapy, and prognosis with second‐line treatment depends largely on the platinum‐free interval. However, reliable biomarkers to predict response to second‐line therapy remain lacking.Muhammad Habiburrahman, Nahal Masrour, Naina Patel, Anna M. Piskorz, Robert Brown, James D. Brenton, Iain A. McNeish, James M. Flanagan +7 morewiley +1 more sourceAn initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance)
, 2019 Federico Innocenti, Chen Jiang, Alexander B. Sibley, Stefanie Denning, Amy S. Etheridge, Dorothy Watson, Donna Niedzwiecki, Ace J. Hatch, Herbert I. Hurwitz, Andrew B. Nixon, Yoichi Furukawa, Michiaki Kubo, Daniel J. Crona, Hedy L. Kindler, Howard L. McLeod, Mark J. Ratain, Kouros Owzar +16 moreopenalex +2 more sourcesComparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study
, 2020 Gerald W. Prager, Leopold Oehler, Armin Gerger, Brigitte Mlineritsch, Johannes Andel, Andreas Petzer, Klaus Wilthoner, Thamer Sliwa, Petra Pichler, Thomas Winder, Sonja Heibl, Birgit Gruenberger, Friedrich Laengle, Eva Hubmann, Markus Korger, Martin Pecherstorfer, Angela Djanani, H Neumann, Kathrin Philipp‐Abbrederis, Ewald Wöll, Robert Trondl, Catharina Arnold‐Schrauf, Wolfgang Eisterer +22 moreopenalex +1 more sourcePhase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma [PDF]
, 2003 Sarah Danson, Mark R. Middleton, Kenneth J. O’Byrne, M. Clemons, Malcolm Ranson, J. Hassan, Helén Anderson, P.A. Burt, Corrine Fairve‐Finn, R. Stout, I. Dowd, Linda Ashcroft, Cheryl Beresford, Nicholas Thatcher +13 moreopenalex +1 more sourcePlasma proteomic profiling and molecular clustering reveal immune‐defined prognostic subtypes in lung adenocarcinoma
International Journal of Cancer, EarlyView.What's New?
Lung adenocarcinoma shows considerable heterogeneity in disease progression and therapeutic response. Here, the authors analyzed tumor samples through proteomic profiling and applied network‐based clustering. They identified two distinct patient groups with different demographic, clinical, and molecular characteristics.Ujjwal Neogi, Anoop T. Ambikan, Kati Turkowski, Marc A. Schneider, Vanessa M. Beutgen, Johannes Graumann, Hauke Winter, Marek Bartkuhn, Werner Seeger, Soni S. Pullamsetti, Rajkumar Savai +10 morewiley +1 more sourceTreatment landscape from first‐ to third‐line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer) registry (IKF‐PARAGON study)
International Journal of Cancer, EarlyView.What's New?
Pancreatic cancer often is diagnosed at advanced stages. As a result, treatment regimens frequently are aggressive, with substantial side effects that impact quality of life (QoL). This study examined the treatment landscape, from neoadjuvant therapy to palliative care, in the context of QoL among pancreatic cancer patients in Germany. Most Thorsten O. Goetze, Salah‐Eddin Al‐Batran, Ruediger Liersch, Lars Scheuer, Thomas Goehler, Ulrich Kaiser, Claudio Denzlinger, Stephan Brandl, Daniel Pink, Jens Uhlig, Michael Maasberg, Maria Loose, Marina Schaaf, Disorn Sookthai, Bianca Zäpf, Claudia Pauligk, Timursah Habibzade, Ralf‐Dieter Hofheinz, Christine Koch, for the AIO Study Group +19 morewiley +1 more sourceCascade‐Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatment Resistance in Pancreatic Cancer [PDF]
Hongrui Fan, Hongyi Chen, Haolin Song, Chufeng Li, Yu Wang, Zhenhao Zhao, Qin Guo, Xuwen Li, Mingxuan Liu, Tao Sun, Chen Jiang +10 moreopenalex +1 more sourceInfluence of body mass index on the therapeutic efficacy of gemcitabine plus cisplatin and overall survival in lung squamous cell carcinoma [PDF]
, 2018 Jia Zhong, Qiwen Zheng, Emei Gao, Zhi Dong, Jun Zhao, Tongtong An, Meina Wu, Minglei Zhuo, Yuyan Wang, Jianjie Li, Shuhang Wang, Xue Yang, Hanxiao Chen, Bo Jia, Jingjing Wang, Ziping Wang +15 moreopenalex +1 more source
